{"entity":{"type":"insider","cik":"0001401650","url":"/insider/0001401650","json_url":"/insider/0001401650.json","name":"NBVM GP, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":5,"first":"2013-08-19","last":"2023-06-02","span_basis":"filed_date"},"name_variants":[{"name":"NBVM GP, LLC","source":"filing","n_filings":5,"first_seen":"2013-08-19","last_seen":"2023-06-02"}],"transactions":[{"id":7834438,"accession":"0000899243-23-014352","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-23-014352","line_url":"/filing/0000899243-23-014352#line-3","is_derivative":false,"issuer_cik":"0001138399","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001138399","owner_cik":null,"owner_name":"NBVM GP, LLC; DAMORE RICHARD A; NORTH BRIDGE VENTURE PARTNERS V A LP; North Bridge Venture Management VI, L.P.; NORTH BRIDGE VENTURE PARTNERS V-B LP; North Bridge Venture Management V, L.P.; North Bridge Venture Partners VI L P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1203612.0,"shares_display":"1,203,612","price_per_share":2.43,"price_display":"2.43","price_state":"stated","total_value":2924777.16,"total_display":"2,924,777.16","shares_owned_after":2521745.0,"shares_owned_after_display":"2,521,745","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-31","filed_date":"2023-06-02","scope":"insider"},{"id":7834433,"accession":"0000899243-23-014352","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-014352","line_url":"/filing/0000899243-23-014352#line-2","is_derivative":false,"issuer_cik":"0001138399","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001138399","owner_cik":null,"owner_name":"NBVM GP, LLC; DAMORE RICHARD A; NORTH BRIDGE VENTURE PARTNERS V A LP; North Bridge Venture Management VI, L.P.; NORTH BRIDGE VENTURE PARTNERS V-B LP; North Bridge Venture Management V, L.P.; North Bridge Venture Partners VI L P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":403858.0,"shares_display":"403,858","price_per_share":2.43,"price_display":"2.43","price_state":"stated","total_value":981374.94,"total_display":"981,374.94","shares_owned_after":2259301.0,"shares_owned_after_display":"2,259,301","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-31","filed_date":"2023-06-02","scope":"insider"},{"id":7834429,"accession":"0000899243-23-014352","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-014352","line_url":"/filing/0000899243-23-014352#line-1","is_derivative":false,"issuer_cik":"0001138399","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001138399","owner_cik":null,"owner_name":"NBVM GP, LLC; DAMORE RICHARD A; NORTH BRIDGE VENTURE PARTNERS V A LP; North Bridge Venture Management VI, L.P.; NORTH BRIDGE VENTURE PARTNERS V-B LP; North Bridge Venture Management V, L.P.; North Bridge Venture Partners VI L P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":197946.0,"shares_display":"197,946","price_per_share":2.43,"price_display":"2.43","price_state":"stated","total_value":481008.78,"total_display":"481,008.78","shares_owned_after":1107370.0,"shares_owned_after_display":"1,107,370","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-31","filed_date":"2023-06-02","scope":"insider"},{"id":6139627,"accession":"0000899243-22-014796","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-014796","line_url":"/filing/0000899243-22-014796#line-3","is_derivative":false,"issuer_cik":"0001138399","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001138399","owner_cik":null,"owner_name":"North Bridge Venture Management VI, L.P.; NBVM GP, LLC; DAMORE RICHARD A; NORTH BRIDGE VENTURE PARTNERS V-B LP; North Bridge Venture Management V, L.P.; NORTH BRIDGE VENTURE PARTNERS V A LP; North Bridge Venture Partners VI L P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1076851.0,"shares_display":"1,076,851","price_per_share":4.22,"price_display":"4.22","price_state":"stated","total_value":4544311.22,"total_display":"4,544,311.22","shares_owned_after":1855443.0,"shares_owned_after_display":"1,855,443","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-12","filed_date":"2022-04-14","scope":"insider"},{"id":6139625,"accession":"0000899243-22-014796","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-014796","line_url":"/filing/0000899243-22-014796#line-2","is_derivative":false,"issuer_cik":"0001138399","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001138399","owner_cik":null,"owner_name":"North Bridge Venture Management VI, L.P.; NBVM GP, LLC; DAMORE RICHARD A; NORTH BRIDGE VENTURE PARTNERS V-B LP; North Bridge Venture Management V, L.P.; NORTH BRIDGE VENTURE PARTNERS V A LP; North Bridge Venture Partners VI L P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":765010.0,"shares_display":"765,010","price_per_share":4.22,"price_display":"4.22","price_state":"stated","total_value":3228342.2,"total_display":"3,228,342.20","shares_owned_after":1318133.0,"shares_owned_after_display":"1,318,133","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-12","filed_date":"2022-04-14","scope":"insider"},{"id":6139621,"accession":"0000899243-22-014796","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-014796","line_url":"/filing/0000899243-22-014796#line-1","is_derivative":false,"issuer_cik":"0001138399","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001138399","owner_cik":null,"owner_name":"North Bridge Venture Management VI, L.P.; NBVM GP, LLC; DAMORE RICHARD A; NORTH BRIDGE VENTURE PARTNERS V-B LP; North Bridge Venture Management V, L.P.; NORTH BRIDGE VENTURE PARTNERS V A LP; North Bridge Venture Partners VI L P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":527806.0,"shares_display":"527,806","price_per_share":4.22,"price_display":"4.22","price_state":"stated","total_value":2227341.32,"total_display":"2,227,341.32","shares_owned_after":909424.0,"shares_owned_after_display":"909,424","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-12","filed_date":"2022-04-14","scope":"insider"},{"id":4141637,"accession":"0001209191-21-048264","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-048264","line_url":"/filing/0001209191-21-048264#line-4","is_derivative":false,"issuer_cik":"0001206641","issuer_name":"Couchbase, Inc.","issuer_ticker":"BASE","issuer_name_source":null,"issuer_url":"/issuer/0001206641","owner_cik":null,"owner_name":"North Bridge Venture Partners VI L P; North Bridge Venture Management 7, L.P.; DAMORE RICHARD A; North Bridge Venture Partners 7, L.P.; NBVM GP, LLC; North Bridge Venture Management VI, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":94791.0,"shares_display":"94,791","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":2274984.0,"total_display":"2,274,984.00","shares_owned_after":2689172.0,"shares_owned_after_display":"2,689,172","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-26","filed_date":"2021-07-26","scope":"insider"},{"id":4141634,"accession":"0001209191-21-048264","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-048264","line_url":"/filing/0001209191-21-048264#line-3","is_derivative":false,"issuer_cik":"0001206641","issuer_name":"Couchbase, Inc.","issuer_ticker":"BASE","issuer_name_source":null,"issuer_url":"/issuer/0001206641","owner_cik":null,"owner_name":"North Bridge Venture Partners VI L P; North Bridge Venture Management 7, L.P.; DAMORE RICHARD A; North Bridge Venture Partners 7, L.P.; NBVM GP, LLC; North Bridge Venture Management VI, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40625.0,"shares_display":"40,625","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":975000.0,"total_display":"975,000.00","shares_owned_after":1987084.0,"shares_owned_after_display":"1,987,084","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-26","filed_date":"2021-07-26","scope":"insider"},{"id":2952700,"accession":"0000899243-20-012179","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-20-012179","line_url":"/filing/0000899243-20-012179#line-9","is_derivative":false,"issuer_cik":"0001138399","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001138399","owner_cik":null,"owner_name":"North Bridge Venture Partners VI L P; NBVM GP, LLC; NORTH BRIDGE VENTURE PARTNERS V A LP; DAMORE RICHARD A; NORTH BRIDGE VENTURE PARTNERS V-B LP; North Bridge Venture Management V, L.P.; North Bridge Venture Management VI, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11360.0,"shares_display":"11,360","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":181760.0,"total_display":"181,760.00","shares_owned_after":661153.0,"shares_owned_after_display":"661,153","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-06","scope":"insider"},{"id":2952697,"accession":"0000899243-20-012179","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-20-012179","line_url":"/filing/0000899243-20-012179#line-8","is_derivative":false,"issuer_cik":"0001138399","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001138399","owner_cik":null,"owner_name":"North Bridge Venture Partners VI L P; NBVM GP, LLC; NORTH BRIDGE VENTURE PARTNERS V A LP; DAMORE RICHARD A; NORTH BRIDGE VENTURE PARTNERS V-B LP; North Bridge Venture Management V, L.P.; North Bridge Venture Management VI, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7255.0,"shares_display":"7,255","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":116080.0,"total_display":"116,080.00","shares_owned_after":478123.0,"shares_owned_after_display":"478,123","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-06","scope":"insider"},{"id":2952691,"accession":"0000899243-20-012179","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-20-012179","line_url":"/filing/0000899243-20-012179#line-7","is_derivative":false,"issuer_cik":"0001138399","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001138399","owner_cik":null,"owner_name":"North Bridge Venture Partners VI L P; NBVM GP, LLC; NORTH BRIDGE VENTURE PARTNERS V A LP; DAMORE RICHARD A; NORTH BRIDGE VENTURE PARTNERS V-B LP; North Bridge Venture Management V, L.P.; North Bridge Venture Management VI, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5568.0,"shares_display":"5,568","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":89088.0,"total_display":"89,088.00","shares_owned_after":324057.0,"shares_owned_after_display":"324,057","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-06","scope":"insider"},{"id":2952687,"accession":"0000899243-20-012179","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-012179","line_url":"/filing/0000899243-20-012179#line-6","is_derivative":false,"issuer_cik":"0001138399","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001138399","owner_cik":null,"owner_name":"North Bridge Venture Partners VI L P; NBVM GP, LLC; NORTH BRIDGE VENTURE PARTNERS V A LP; DAMORE RICHARD A; NORTH BRIDGE VENTURE PARTNERS V-B LP; North Bridge Venture Management V, L.P.; North Bridge Venture Management VI, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":117439.0,"shares_display":"117,439","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":1879024.0,"total_display":"1,879,024.00","shares_owned_after":778592.0,"shares_owned_after_display":"778,592","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-06","scope":"insider"},{"id":2952684,"accession":"0000899243-20-012179","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-20-012179","line_url":"/filing/0000899243-20-012179#line-5","is_derivative":false,"issuer_cik":"0001138399","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001138399","owner_cik":null,"owner_name":"North Bridge Venture Partners VI L P; NBVM GP, LLC; NORTH BRIDGE VENTURE PARTNERS V A LP; DAMORE RICHARD A; NORTH BRIDGE VENTURE PARTNERS V-B LP; North Bridge Venture Management V, L.P.; North Bridge Venture Management VI, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":1200000.0,"total_display":"1,200,000.00","shares_owned_after":553123.0,"shares_owned_after_display":"553,123","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-06","scope":"insider"},{"id":2952680,"accession":"0000899243-20-012179","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-012179","line_url":"/filing/0000899243-20-012179#line-4","is_derivative":false,"issuer_cik":"0001138399","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001138399","owner_cik":null,"owner_name":"North Bridge Venture Partners VI L P; NBVM GP, LLC; NORTH BRIDGE VENTURE PARTNERS V A LP; DAMORE RICHARD A; NORTH BRIDGE VENTURE PARTNERS V-B LP; North Bridge Venture Management V, L.P.; North Bridge Venture Management VI, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":57561.0,"shares_display":"57,561","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":920976.0,"total_display":"920,976.00","shares_owned_after":381618.0,"shares_owned_after_display":"381,618","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-06","scope":"insider"},{"id":5448002,"accession":"0001181431-13-045521","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-045521","line_url":"/filing/0001181431-13-045521#line-1","is_derivative":false,"issuer_cik":"0001138399","issuer_name":"Demandware Inc","issuer_ticker":"DWRE","issuer_name_source":null,"issuer_url":"/issuer/0001138399","owner_cik":null,"owner_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP; North Bridge Venture Management V, L.P.; ANDERSON EDWARD T; DAMORE RICHARD A; NBVM GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":131.0,"shares_display":"131","price_per_share":45.55,"price_display":"45.55","price_state":"stated","total_value":5967.05,"total_display":"5,967.05","shares_owned_after":473902.0,"shares_owned_after_display":"473,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-15","filed_date":"2013-08-19","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001327273","name":"Lyra Therapeutics, Inc.","url":"/issuer/0001327273","role":"Ten percent owner","n_filings":3,"first_seen":"2020-05-06","last_seen":"2023-06-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001845022","name":"Couchbase, Inc.","url":"/issuer/0001845022","role":"Ten percent owner","n_filings":1,"first_seen":"2021-07-26","last_seen":"2021-07-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001301031","name":"Demandware Inc","url":"/issuer/0001301031","role":"Ten percent owner","n_filings":1,"first_seen":"2013-08-19","last_seen":"2013-08-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001401650","retrieved_at":"2026-08-21T20:24:09+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}